2025: A Breakthrough Year for Drug Innovation – 10 First-in-Class and First-Ever Treatments Approved in 2025

2025 has seen 43 novel FDA drug approvals – new drugs never before approved or marketed in the U.S – introducing high-impact therapies that are redefining what “breakthrough” truly means. This year’s portfolio highlights durable formulations…

A Year of Innovation & Impact – TrialX Year-In-Review 2024🏅

“As we close 2024, I’m proud of the transformative strides we’ve made in advancing software solutions for patient recruitment and remote data collection. From simplifying recruitment workflows with AI-powered tools and streamlining volunteer registries to enhancing…